Related Experiment Video
Updated: Aug 5, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Triterpenoids and Lignans From Schisandra henryi subsp. yunnanensis A. C. Smith
Ya-Ying Cao1,2, Kun Hu1, Xiao-Nian Li1
1State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, People's Republic of China.
Abstract:
Three new triterpenoids, henridilactones P-R (1-3) and two new dibenzocyclooctadiene lignans, henrilignans A and B (11 and 12), alongside twelve known analogues (4-10 and 13-17) were isolated from the stems and leaves of Schisandra henryi subsp. yunnanensis. The structures and absolute configurations of new compounds were elucidated by comprehensive 1D and 2D NMR, HRESIMS, electronic circular dichroism analyses, and theoretical calculations. In bioactivity evaluation, the isolated triterpenoids (1-10) exhibited moderate neurite outgrowth in differentiated PC12 cells at 10 µM (differentiation rates 10.09%-12.96%; positive control 50 ng/mL NGF, 19.71%). Furthermore, henridilactone P (1) exhibited a binding affinity with an equilibrium dissociation constant (KD) of 3.286 × 10- 4 M (reference compound PF-06446846, KD = 8.008 × 10- 5 M).